Alzheimer's Disease: Skin Cancer Drug Sparks Hope, Desperation - ABC News

Alzheimer's Disease: Skin Cancer Drug Sparks Hope, Desperation - ABC News: Because bexarotene is already approved by the U.S. Food and Drug Administration for skin cancer, doctors can legally prescribe it "off-label" for other conditions. But Alzheimer's experts urge families to temper their hope until the drug is proved safe and effective by years of clinical trials -- a tall order for the country's 5.4 million patients and 14.9 million caregivers.